These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Further observations on Klebsiella molecular cross-reactivity in HLA-B27 positive persons. Trull AK; Panayi GS J Rheumatol; 1985 Oct; 12(5):1024. PubMed ID: 3910831 [No Abstract] [Full Text] [Related]
43. Seronegative spondyloarthropathies and HLA antigens in a Mestizo population. Pérez-Rojas GE; Paul-Moya H; Bianco NE; Abadí I Tissue Antigens; 1984 Feb; 23(2):107-11. PubMed ID: 6710473 [TBL] [Abstract][Full Text] [Related]
44. [Study of HLA antigens A and B and their cross reactions in B27-negative ankylosing spondylarthritis]. Dreyfus P; Geay D; Cambon H; Daupleix D Rev Rhum Mal Osteoartic; 1984 May; 51(5):269-72. PubMed ID: 6610919 [TBL] [Abstract][Full Text] [Related]
45. Reactive arthritis or Reiter's syndrome and B51-associated seronegative spondyloarthropathy. Kobayashi S; Ando S Intern Med; 2000 Feb; 39(2):89. PubMed ID: 10732822 [No Abstract] [Full Text] [Related]
46. [Explanatory models for HLA-b27 association of reactive arthritis as a paradigm for spondyloarthropathy]. Braun J; Sieper J Med Klin (Munich); 1996 Sep; 91(9):574-9. PubMed ID: 8984316 [No Abstract] [Full Text] [Related]
47. Clinical aspects, outcome assessment, and management of ankylosing spondylitis and postenteric reactive arthritis. van der Linden S; van der Heijde D Curr Opin Rheumatol; 2000 Jul; 12(4):263-8. PubMed ID: 10910177 [TBL] [Abstract][Full Text] [Related]
48. Reaction of anti-HLA-B monoclonal antibodies with envelope proteins of Shigella species. Evidence for molecular mimicry in the spondyloarthropathies. Raybourne RB; Bunning VK; Williams KM J Immunol; 1988 May; 140(10):3489-95. PubMed ID: 3283236 [TBL] [Abstract][Full Text] [Related]
52. HLA-B27 associated reactive spondyloarthropathies in a Dutch military hospital. Lionarons RJ; van Zoeren M; Verhagen JN; Lammers HA Ann Rheum Dis; 1986 Feb; 45(2):141-3. PubMed ID: 3484936 [TBL] [Abstract][Full Text] [Related]
54. Coexistence of HLA-B27 ankylosing spondylitis and DR4 seropositive nodular rheumatoid arthritis in patient with membranous nephropathy. Lemmer JP; Irby WR J Rheumatol; 1981; 8(4):661-4. PubMed ID: 6975378 [TBL] [Abstract][Full Text] [Related]
55. [HLA-B27 antigen in ankylosing spondylitis and its role in the etiopathogenesis of the disease]. Jajić I; Kastelan A Reumatizam; 1977; 24(6):195-200. PubMed ID: 601354 [No Abstract] [Full Text] [Related]
56. New views on B27 associated diseases. Feltkamp TE Neth J Med; 1989 Oct; 35(3-4):119-22. PubMed ID: 2689893 [No Abstract] [Full Text] [Related]
57. HLA-B27: speculations on the nature of its involvement in ankylosing spondylitis. Upfold LI; Sullivan JS; Prendergast JK; Geczy AF Prog Allergy; 1985; 36():177-89. PubMed ID: 3881781 [No Abstract] [Full Text] [Related]
58. HLA B27 in the population of northern Sweden. Bjelle A; Cedergren B; Dahlqvist SR Scand J Rheumatol; 1982; 11(1):23-6. PubMed ID: 6977838 [TBL] [Abstract][Full Text] [Related]
59. Pathogenesis of ankylosing spondylitis: the state of the art. Calin A Br J Rheumatol; 1988; 27 Suppl 2():106-9. PubMed ID: 3042068 [No Abstract] [Full Text] [Related]
60. Seronegative spondyloarthropathies and IgA glomerulonephritis: a report of four cases and a review of the literature. Bruneau C; Villiaumey J; Avouac B; Martigny J; Laurent J; Pichot A; Belghiti D; Lagrue G Semin Arthritis Rheum; 1986 Feb; 15(3):179-84. PubMed ID: 3515560 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]